Chronic Lyme disease treatments tied to serious adverse effects

June 20, 2017

(HealthDay)—Serious bacterial infections have been documented during treatment for chronic Lyme disease, according to research published in the June 16 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Noting that chronic Lyme disease is used by some as a diagnosis for constitutional, musculoskeletal, and , Natalie S. Marzec, M.D., from the University of Colorado in Aurora, and colleagues address the issue of serious bacterial infections during treatments for chronic Lyme disease, detailing five illustrative cases.

The authors note that patients with a diagnosis of chronic Lyme disease are treated with a wide range of medications, including long courses of intravenous antibiotics. These treatments have not been shown to result in substantial long-term improvement, and they can be harmful. Cases of septic shock, osteomyelitis, Clostridium difficile colitis, and paraspinal abscess have been documented as a result of chronic Lyme disease treatments.

"Patients, clinicians, and public health practitioners should be aware that treatments for chronic Lyme disease can carry serious risks," the authors write.

Explore further: No Lyme disease in Australia, new research finds

More information: Abstract/Full Text

Related Stories

No Lyme disease in Australia, new research finds

October 31, 2016
Lyme disease cannot be contracted in Australia and patients should not be treated with antibiotics for so-called Lyme-like diseases, new medical research has found.

Lyme disease 'Biofilm' eludes antibiotics: report

February 25, 2016
(HealthDay)—The bacteria that causes Lyme disease protects itself from antibiotics by forming a slime-like layer called a biofilm, a new study shows.

New national Lyme Disease biobank to accelerate research by making samples available

January 24, 2017
Bay Area Lyme Foundation, a national organization funding research to make Lyme disease easy to diagnose and simple to cure, announces the launch of the Lyme Disease Biobank, which is the first program to provide researchers ...

New Lyme disease estimate: 300,000 cases a year

August 19, 2013
Health officials say Lyme disease is about 10 times more common than previously reported.

Gene signature could lead to a new way of diagnosing Lyme

February 12, 2016
Researchers at UC San Francisco and Johns Hopkins may have found a new way to diagnose Lyme disease, based on a distinctive gene "signature" they discovered in white blood cells of patients infected with the tick-borne bacteria.

Recommended for you

Cancer drug helps treat tuberculosis by restoring leaky blood vessels

April 26, 2018
Biomedical engineers have discovered an unlikely potential ally in the global fight against tuberculosis—an FDA-approved drug originally designed to treat cancer.

Molecule may help tame virulent bacteria and prevent infection

April 26, 2018
According to the U.S. Centers for Disease Control and Prevention, about one in three humans carries Staphylococcus aureus, or "staph," in our noses, and 2 percent of us carry the dreaded methicillin-resistant (MRSA) strain ...

Antibody 'cocktail' can prevent Zika infection but is not effective for treatment of fetuses

April 26, 2018
A "cocktail" of monoclonal antibodies that can prevent Zika virus (ZIKV) infection in primates was not effective for treatment of fetuses, according to a new collaborative study led by a University of Miami Miller School ...

E. coli—are we measuring the wrong thing?

April 25, 2018
A sepsis awareness and management programme has demonstrated overall success in terms of improved sepsis detection, but has led to an increase in the number of E. coli blood stream infection cases presented, calling into ...

Malaria study reveals gene variants linked to risk of disease

April 25, 2018
Many people of African heritage are protected against malaria by inheriting a particular version of a gene, a large-scale study has shown.

Commonly prescribed heartburn drug linked to pneumonia in older adults

April 24, 2018
Researchers at the University of Exeter have found a statistical link between pneumonia in older people and a group of medicines commonly used to neutralise stomach acid in people with heartburn or stomach ulcers. Although ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.